London Capital Investment Partners's Gainsborough partnership invests in companies quoted on AIM and Plus markets. The partnership will develop a portfolio of approximately 20 companies. Gainsborough will allocate 20% of its funds to approximately 10 ''Earlier Companies'' and 80% of its assets to approximately 10 Later Companies. This defensive asset allocation profile will give partners exposure to exciting younger companies, while giving the portfolio a base of more developed companies.

To date the partnership has invested in the following companies: * Plastics Capital plc (http://www.plasticscapital.com/) * Surface Transforms plc (http://www.surface-transforms.com/) * Immunodiagnostic Systems Holdings plc (http://www.idsltd.com) * BrainJuicer Group plc (www.brainjuicer.com) * Scancell Holdings plc (www.scancell.co.uk)